Phase 3 Trial Results Continue to Show the Efficacy of Orencia as a Treatment for Juvenile Idiopathic Arthritis
Orencia Orencia (abatacept) is a treatment for juvenile idiopathic arthritis (JIA) that was approved for use in the U.S. for the pediatric patient population in 2008. In Japan, the therapy…